IGO Q1 2027 slides: record lithium output offsets refinery losses

IGO reported Q1 FY2027 underlying EBITDA of A$176 million, up 49% quarter over quarter, including a A$32 million mark-to-market gain; excluding that gain, EBITDA rose about 13%. Greenbushes achieved record production of 435,000 tonnes of spodumene concentrate, while Kwinana posted a A$65.4 million EBITDA loss and Nova delivered its final full production quarter ahead of planned divestment. Net cash was A$376 million, and shares traded down 2.1% at A$5.09.

Analysis

The quarter is better read as a portfolio-quality transition than a clean earnings inflection. Excluding the listed-investment mark, the sequential EBITDA improvement is modest; Nova’s unusually strong final quarter is also a temporary contribution that disappears after divestment. The key valuation question is whether Greenbushes distributions can replace that cash generation—not simply whether its mine output is growing. IGO’s increasing dependence on a partner-controlled asset also makes distributions and capital allocation at TLEA material risks outside IGO’s direct operating control.

Greenbushes’ cost position and improved throughput provide resilience if lithium prices weaken, but the record quarter is not yet proof of sustained higher earnings: grade, recovery, realized prices, and the partner’s budget all matter. Conversely, Kwinana’s headline loss may overstate recurring cash leakage if NRV adjustments account for a material share; the article does not give the split. Treat the refinery as an unresolved option, not as evidence that downstream conversion will soon create value.

Near term, expect scrutiny of earnings quality and the December-quarter Nova transfer. Over 1–3 months, the catalysts are confirmation of CGP3 performance, Kwinana’s post-shutdown operating data, and clarity on its strategic pathway. Over 6–18 months, the structural debate is whether IGO can redeploy capital into copper without diluting the value of its lithium exposure. The contrarian risk is that investors either capitalize a single strong mine quarter too aggressively or discount Greenbushes’ low-cost resilience because of Kwinana. Falsifiers: sustained deterioration in Greenbushes costs/recovery, materially weaker TLEA distributions, or Kwinana losses persisting after the NRV effects and ramp-up period normalize.

Key Decisions for Investors

• No immediate directional IGO position on this quarter alone: reported EBITDA quality and the temporary Nova contribution make the headline improvement a poor run-rate anchor. Reassess after the Nova transfer and the next TLEA distribution disclosure.
• Prefer exposure to low-cost lithium upstream producers over lithium conversion/refining businesses while Kwinana’s pathway remains unresolved. Treat this as a sector relative-value bias, not a claim that IGO’s unlisted JV exposure is directly tradable.
• Set an alert for the next quarter: verify Greenbushes grade, recovery, unit costs and realized pricing; separate Kwinana cash operating performance from NRV adjustments; and track TLEA distributions. A deterioration in upstream costs or distributions would invalidate the resilience thesis.
• Watch the December-quarter Nova divestment for proceeds, completion conditions, and any change to cash-flow guidance. If the exit removes more recurring cash generation than Greenbushes distributions replace, reassess IGO’s capital-allocation capacity before giving credit to its copper growth pipeline.